Search Results - "Fuentealba, Paulina"

Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the OneCare study by Gomez‐Peralta, Fernando, Chico Ballesteros, Ana, Marco Martínez, Amparo, Pérez Corral, Begoña, Conget Donlo, Ignacio, Fuentealba Melo, Paulina, Zaragozá Arnáez, Fernando, Matabuena Rodríguez, Marcos

Get full text

Insulin glargine 300U/ml versus insulin degludec 100U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the OneCare study by Fernando Gomez‐Peralta, Ana Chico Ballesteros, Amparo Marco Martínez, Begoña Pérez Corral, Ignacio Conget Donlo, Paulina Fuentealba Melo, Fernando Zaragozá Arnáez, Marcos Matabuena Rodríguez

Get full text

717-P: Effect of Telephone Coaching Support on Glycemic Control in Type 2 Diabetes Treated with Glargine U300 Insulin by GUERRERO, DIEGO BELLIDO, BELLIDO, VIRGINIA, MORALES, CRISTOBAL, GARCÍA, JOSÉ, MUÑOZ-GARACH, ARACELI, FERNANDEZ MORERA, JUAN LUIS, AGUILERA, BEATRIZ GONZALEZ, LÓPEZ DE LA TORRE, MARTÍN, FUENTEALBA, PAULINA

“…Background and Aims: “T-Coach® program” is a telephone support platform for type 2 diabetes (T2D) on glargine U300 insulin. This study aimed to evaluate…”
Get full text

Once-Monthly Administration of Darbepoetin Alfa for the Treatment of Patients with Chronic Heart Failure and Anemia: A Pharmacokinetic and Pharmacodynamic Investigation by Cleland, John G. F, Sullivan, John T, Ball, Stephen, Horowitz, John D, Agoram, Balaji, Rosser, Dylan, Yates, Wayne, Tin, Lwin, Fuentealba, Paulina, Burton, Paul B. J

“…In patients with chronic heart failure (CHF), anemia is associated with more severe symptoms and worse prognosis. Erythropoiesis-stimulating proteins (ESPs)…”
Get full text